CD24 and infection: To conclude, we investigate ICD signatures following oZIKV infection of paediatric brain tumour cells and propose TNF-alpha as a potential prognostic marker for brain tumour oZIKV therapy, with the only other known prognostic marker being CD24 for neuroblastoma oZIKV therapy61.